ClassID:

109551

C12N2517/02 - CPC Classification

Classification description:

Cells related to new breeds of animals Cells from transgenic animals

Recent Application in this class:
#1
20260092259
2026-04-02

CELL ADHESION SYSTEM FOR INTERSPECIES CHIMERAS

#2
20250354165
2025-11-20

TRANSGENIC MOUSE MODELS SUPPORTING INNATE IMMUNE FUNCTION

#3
20250276014
2025-09-04

GENETICALLY ENGINEERED INNATE LYMPHOID CELLS FOR ENHANCING LIFESPAN AND/OR TREATING CANCERS

#4
20250151705
2025-05-15

PROCESS OF TRANSFECTING PRIMORDIAL GERM CELLS IN AN AVIAN

#5
20250120373
2025-04-17

TRIPLE TRANSGENIC PIGS SUITABLE FOR XENOGRAFT

#6
20250000070
2025-01-02

HUMANIZED T CELL CO-RECEPTOR MICE

#7
20240397919
2024-12-05

NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3

#8
20230189769
2023-06-22

Process for using CRISPR to transfect primordial germ cells in avians

#9
20220330532
2022-10-20

NON-HUMAN ANIMALS HAVING A LIMITED LAMBDA LIGHT CHAIN REPERTOIRE EXPRESSED FROM THE KAPPA LOCUS AND USES THEREOF

#10
20220136002
2022-05-05

TRANSGENIC MOUSE MODELS SUPPORTING INNATE IMMUNE FUNCTION

#11
20210360908
2021-11-25

Non-human animals having a humanized lymphocyte-activation gene 3

#12
20210251202
2021-08-19

NON-HUMAN ANIMALS CAPABLE OF DH-DH REARRANGEMENT IN THE IMMUNOGLOBULIN HEAVY CHAIN CODING SEQUENCES

#13
20210161110
2021-06-03

Humanized skeletal muscle

#14
20210112789
2021-04-22

Process of transfecting primordial germ cells in an avian

#15
20210068378
2021-03-11

Humanized T cell co-receptor mice

#16
20210008194
2021-01-14

MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production

#17
20200077632
2020-03-12

Genetically engineered non-human mammal, construction method therefor and use thereof

#18
20190320632
2019-10-24

Non-human animals having a humanized lymphocyte-activation gene 3

#19
20190320630
2019-10-24

Transgenic animal for production of antibodies having minimal CDRs

#20
20190261609
2019-08-29

Process for using crispr to transfect primordial germ cells in avians

#21
20190141967
2019-05-16

Transgenic animal for production of antibodies having minimal CDRs

#22
20190017021
2019-01-17

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#23
20180338479
2018-11-29

Transgenic animal for production of antibodies having minimal CDRS

#24
20180311337
2018-11-01

MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production

#25
20180258399
2018-09-13

Method of making trabecular bone

#26
20180177166
2018-06-28

Humanized skeletal muscle

#27
20180177164
2018-06-28

Method for producing blood chimeric animal

#28
20180163206
2018-06-14

In vivo production of small interfering RNAs that mediate gene silencing

#29
20180084768
2018-03-29

Humanized T cell co-receptor mice

#30
20170295762
2017-10-19

Methods and compositions for generating a mouse

#31
20170218399
2017-08-03

Production of fertile XY female mice from XY mouse ES cells

#32
20170218336
2017-08-03

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#33
20170198306
2017-07-13

ENGINEERING MAMMALIAN GENOME USING DNA-GUIDED ARGONAUTE INTERFERENCE SYSTEMS (DAIS)

#34
20170156298
2017-06-08

Transgenic animal for production of antibodies having minimal CDRS

#35
20170145423
2017-05-25

Use of Mcoln-1 modulators to regulate cell migration

#36
20170142943
2017-05-25

Non-human animals having a humanized lymphocyte-activation gene 3

#37
20160362685
2016-12-15

In vivo production of small interfering RNAs that mediate gene silencing

#38
20160316729
2016-11-03

Methods and compositions for generating a mouse

#39
20160316728
2016-11-03

ES Cell-Derived Mice From Diploid Host Embryo Injection

#40
20160295841
2016-10-13

Production of fertile XY female animals from XY ES cells

#41
20150223436
2015-08-13

Hematopoietic stem cell specific reporter mouse and uses thereof

#42
20150175958
2015-06-25

Cell line derived from thread-sail filefish ()

#43
20150082471
2015-03-19

Method for culturing avian gonocytes

#44
20150072064
2015-03-12

Method of making a chicken with germ cells expressing marker protein

#45
20150052625
2015-02-19

HUMANIZED MOUSE

#46
20140223589
2014-08-07

Animal models of duchenne muscular dystrophy

#47
20140179760
2014-06-26

In vivo production of small interfering RNAs that mediate gene silencing

#48
20130171665
2013-07-04

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#49
20120295351
2012-11-22

Method for cloning pluripotent stem cells

#50
20120201788
2012-08-09

METHODS AND COMPOSITIONS FOR CELL THERAPY

#51
20120156179
2012-06-21

Method for inducing extended self-renewal of functionally differentiated somatic cells

#52
20120076761
2012-03-29

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease

#53
20110307968
2011-12-15

Production of fertile XY animals from XY ES cells

#54
20110244470
2011-10-06

Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders

#55
20110207224
2011-08-25

In vivo production of small interfering RNAs that mediate gene silencing

#56
20110201557
2011-08-18

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

#57
20110185440
2011-07-28

CISD2-Knockout Mice and Uses Thereof

#58
20110179510
2011-07-21

Sustained culture of avian gonocytes

#59
20110177595
2011-07-21

Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof

#60
20110099644
2011-04-28

knockout mice and elucidation of association of with early onset degenerative joint disease and role as a tumor suppressor

#61
20110093963
2011-04-21

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#62
20110061119
2011-03-10

METHOD OF PRODUCING NON-HUMAN MAMMALS

#63
20110055941
2011-03-03

Chd5 is a novel tumor suppressor gene

#64
20110055938
2011-03-03

Transgenic animal for production of antibodies having minimal CDRS

#65
20110052500
2011-03-03

TAJ in Neuronal Function

#66
20110021413
2011-01-27

Methods of suppressing microglial activation

#67
20100287632
2010-11-11

Rapid production of monoclonal antibodies

#68
20100273660
2010-10-28

ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS

#69
20100251395
2010-09-30

Using cytosine deaminases to diminish retroelement transfer from pigs to humans

#70
20100234448
2010-09-16

Vivo production of small interfering RNAs that mediate gene silencing

#71
20100233810
2010-09-16

In vivo production of small interfering RNAS that mediate gene silencing

#72
20100083393
2010-04-01

METHOD OF CONSTRUCTING CLONE MAMMAL

#73
20090271884
2009-10-29

ES Cell-Derived Mice From Diploid Host Embryo Injection

#74
20090253902
2009-10-08

Isolated human chromosome 14 fragment encoding immunoglobulin genes

#75
20090253731
2009-10-08

Method of identifying therapeutic agents

#76
20090253176
2009-10-08

Cell lines and methods for producing proteins

#77
20090249501
2009-10-01

CISD2-Knockout Mice and Uses Thereof

#78
20090233986
2009-09-17

Methods and compositions for using sax2

#79
20090220465
2009-09-03

METHODS AND COMPOSITIONS FOR MODULATION OF STEM CELL AGING

#80
20090185997
2009-07-23

Methods of suppressing microglial activation and systemic inflammatory responses

#81
20090169614
2009-07-02

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES

#82
20090151011
2009-06-11

Chimeric Non-Human Animal and Use Thereof

#83
20090136464
2009-05-28

Methods and compositions for cell therapy

#84
20090117101
2009-05-07

HEH4 Molecules and Uses Thereof

#85
20090092588
2009-04-09

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease

#86
20090081170
2009-03-26

Cardiac progenitor cells

#87
20090053210
2009-02-26

Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals

#88
20090049563
2009-02-19

USING CYTOSINE DEAMINASES TO DIMINISH RETROELEMENT TRANSFER FROM PIGS TO HUMANS

#89
20090029872
2009-01-29

Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof

#90
20080313748
2008-12-18

Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them

#91
20080300184
2008-12-04

TRANSGENIC TIEG NON-HUMAN ANIMALS

#92
20080268445
2008-10-30

Ant2 Conditional Knockout Mouse and Methods

#93
20080200420
2008-08-21

In vivo production of small interfering RNAs that mediate gene silencing

#94
20080152643
2008-06-26

Compositions and methods for treatment of autoimmune and related diseases

#95
20080146506
2008-06-19

Methods of suppressing microglial activation

#96
20080127360
2008-05-29

Swine Cell For Xenotransplantation, Method of Selecting the Same and Swine For Xenotransplantation

#97
20080104719
2008-05-01

CISD2-Knockout Mice and Uses Thereof

#98
20080078001
2008-03-27

Method for making homozygous genetic modifications

#99
20080078000
2008-03-27

Conditioned culture media

#100
20080044392
2008-02-21

Isolation of Stem Cell-Like Cells and Use Thereof

#101
20080032926
2008-02-07

Knockout Non-Human Animal

#102
20080028479
2008-01-31

Method for making genetic modifications

#103
20070289029
2007-12-13

Means and methods for producing a stabilized cell of interest

#104
20070283452
2007-12-06

Animal model for identifying agents that inhibit or enhance CTLA4 signaling

#105
20070274954
2007-11-29

Cloning B and T lymphocytes

#106
20070250942
2007-10-25

Non-human transgenic mammals useful for identifying and assessing neural stem/progenitor cells

#107
20070231331
2007-10-04

Methods for screening agents that modulate presenilin activity and A-β production

#108
20070220621
2007-09-20

Genetic characterization and prognostic significance of cancer stem cells in cancer

#109
20070209083
2007-09-06

Cell and transgenic animal modelling human antigenic presentation and their uses

#110
20070207539
2007-09-06

Genetically altered hybridomas, myelomas and B cells that facilitate the rapid production of monoclonal antibodies

#111
20070204357
2007-08-30

Process for producing normal parenchymal cells, tissues or organs by bioincubator

#112
20070190035
2007-08-16

Diabetes treatment methods and drug targets therefor

#113
20070148706
2007-06-28

Pancreatic progenitor cells and methods for isolating the same

#114
20070130631
2007-06-07

TAAR1 transgenic animal

#115
20070130628
2007-06-07

Method for producing immortalised antibodies-secreting cells

#116
20070118915
2007-05-24

TRANSGENIC MICE COMPRISING A GENOMIC HUMAN TAU TRANSGENE

#117
20070107076
2007-05-10

Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo

#118
20070104679
2007-05-10

Induction of differentiation of stem cells, and control of differentiation potency of stem cells

#119
20070101445
2007-05-03

Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases

#120
20070074298
2007-03-29

Versican and epithelial-mesenchymal interaction

#121
20070067861
2007-03-22

Cloning pigs using donor nuclei from differentiated cells

#122
20070061908
2007-03-15

Methods of obtaining neural stem cells

#123
20070033666
2007-02-08

Using cytosine deaminases to diminish retroelement transfer from pigs to humans

#124
20070031392
2007-02-08

Delivery vehicle for recombinant proteins

#125
20070028316
2007-02-01

Transgenic non-human Act1-deficient mammals and uses thereof

#126
20070011757
2007-01-11

Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein

#127
20070010897
2007-01-11

Immunochemically modified and sterilized xenografts and allografts

#128
20060272041
2006-11-30

Cathepsin G (CTSG) Disruptions, Compositions and Methods Relating Thereto

#129
20060265767
2006-11-23

Compositions and methods for treatment of autoimmune and related diseases

#130
20060259992
2006-11-16

Animal models of long QT syndrome and uses thereof

#131
20060242722
2006-10-26

Method to enrich for α(1,3)-galactosyltransferase null pig cells

#132
20060242720
2006-10-26

Inducible site-directed mutagenesis through conditional gene rescue

#133
20060236415
2006-10-19

Neural crest cells specific promoters; isolated neural crest cells; and methods of isolating and of using same

#134
20060230466
2006-10-12

Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof

#135
20060206952
2006-09-14

Transgenic chickens

#136
20060195916
2006-08-31

Transgenic animal as a model for fibrotic diseases

#137
20060174363
2006-08-03

Germline transmission of avian primordial germ cells (PGCs)

#138
20060174362
2006-08-03

Long-term culture of avian primordial germ cells (PGCs)

#139
20060174360
2006-08-03

Non-inbred embryonic stem cells having good developmental potential

#140
20060162000
2006-07-20

Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancer

#141
20060156422
2006-07-13

Methods and compositions for the generation of antibodies

#142
20060127397
2006-06-15

RAG polypeptides, nucleic acids, and their use

#143
20060123501
2006-06-08

Method for treating inflammatory disorders

#144
20060110377
2006-05-25

Immunologically privileged cells and uses thereof

#145
20060107340
2006-05-18

Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto

#146
20060105459
2006-05-18

Transgenic mice containing NTTP1 phosphatase gene disruptions

#147
20060088509
2006-04-27

Isolated clk-1 -/- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders

#148
20060085866
2006-04-20

Method for generating an animal homozygous for a genetic modification

#149
20060083722
2006-04-20

Methods and compositions for cell therapy

#150
20060075511
2006-04-06

Muir-Torre-like syndrome in Fhit deficient mice

#151
20060067914
2006-03-30

Immortalized natural killer cell line

#152
20060059576
2006-03-16

Treatment of neurodegenerative conditions with nimesulide

#153
20060058223
2006-03-16

Methods of promoting neurite outgrowth with soluble TAJ polypeptides

#154
20060057719
2006-03-16

Carbohydrate determinant selection system for homologous recombination

#155
20060048238
2006-03-02

Transgenic TIEG non-human animals

#156
20060037089
2006-02-16

In vivo models for rabGEF1-dependent signaling and functions

#157
20060031953
2006-02-09

Mutant mice comprising a mutated type II procollagen alpha-1

#158
20060024280
2006-02-02

Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis

#159
20060015955
2006-01-19

Alpha(1,3)Galactosyltransferase enzyme that assembles the Galalpha(1,3)Gal xenoantigen

#160
20060015948
2006-01-19

Zebrafish assay

#161
20060009402
2006-01-12

In vivo production of small interfering RNAS that mediate gene silencing

#162
20060008797
2006-01-12

Methods of suppressing microglial activation

#163
20060008451
2006-01-12

In vivo methods for effecting tissue specific differentiation of embryonic stem cells

#164
20060003311
2006-01-05

In vitro screening of cellular events using 3d cell culture systems

#165
20050287581
2005-12-29

Gene sequence of alpha(1,3)galactosyltransferase

#166
20050283844
2005-12-22

Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof

#167
20050232863
2005-10-20

Longevity and PAPP-A

#168
20050208030
2005-09-22

Myocardial grafts and cellular compositions useful for same

#169
20050177887
2005-08-11

Somatic cells, germ cells and cell lines derived from a PTTG knockout rodent

#170
20050172351
2005-08-04

Animal model for identifying agents that inhibit or enhance CTLA4 signaling

#171
20050158308
2005-07-21

HEH4 molecules and uses thereof

#172
20050144660
2005-06-30

Mouse models for studying and treating hepatocellular and gastrointestinal tumors

#173
20050120400
2005-06-02

α(1,3)-galactosyltransferase knockout swine, tissues and organs

#174
20050120398
2005-06-02

Animal model for HCV infection

#175
20050108785
2005-05-19

Cloning using donor nuclei from differentiated fetal and adult cells

#176
20050091704
2005-04-28

Ant2 conditional knockout mouse and methods

#177
20050090001
2005-04-28

Cell lines and methods for producing proteins

#178
20050081257
2005-04-14

Method of producing non-human mammals

#179
20050074439
2005-04-07

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease

#180
20050066375
2005-03-24

Cell and transgenic animal modelling human antigenic presentation and their uses

#181
20050063960
2005-03-24

Dna construct for assessing thymic function activity and therapeutical uses thereof

#182
20050034184
2005-02-10

Transgenic mouse lacking PAPP-A activity

#183
20050026292
2005-02-03

GLYT1 conditional knock-out mice

#184
20050015822
2005-01-20

Mass 1 gene, a target for anticonvulsant drug development